Holen Sie sich die Stockscreener-App
46.88
1.62%
-0.77
Handel nachbörslich:
46.88
Schlusskurs vom Vortag:
$47.65
Offen:
$47.75
24-Stunden-Volumen:
1.98M
Relative Volume:
0.95
Marktkapitalisierung:
$9.66B
Einnahmen:
$2.09B
Nettoeinkommen (Verlust:
$424.88M
KGV:
22.94
EPS:
2.0439
Netto-Cashflow:
$447.20M
1W Leistung:
-3.58%
1M Leistung:
-9.34%
6M Leistung:
-0.34%
1J Leistung:
+23.96%
1-Tages-Spanne:
$46.71
$47.98
1-Wochen-Bereich:
$46.71
$49.86
52-Wochen-Spanne:
$37.92
$57.81
Qiagen Nv Stock (QGEN) Company Profile
Firmenname
Qiagen Nv
Sektor
Branche
Telefon
-
Adresse
-
Compare QGEN vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
46.88 | 9.82B | 2.09B | 424.88M | 447.20M | 2.0439 |
|
TMO
Thermo Fisher Scientific Inc
|
512.69 | 190.90B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
204.73 | 144.26B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
648.70 | 50.60B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
120.54 | 33.67B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.04 | 30.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-22 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-06-24 | Eingeleitet | Barclays | Overweight |
| 2025-04-04 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | Hochstufung | Jefferies | Hold → Buy |
| 2024-10-17 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-06-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-12-07 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-12 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-05-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-01-18 | Hochstufung | DZ Bank | Hold → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-10-14 | Eingeleitet | Redburn | Buy |
| 2021-07-14 | Herabstufung | Kepler | Buy → Hold |
| 2021-06-03 | Eingeleitet | Goldman | Neutral |
| 2020-10-06 | Fortgesetzt | BofA Securities | Buy |
| 2020-09-28 | Hochstufung | Kepler | Hold → Buy |
| 2020-08-24 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-08-17 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-08-14 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | Herabstufung | Berenberg | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-12-26 | Fortgesetzt | BofA/Merrill | Underperform |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-11-14 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-11-14 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2019-11-14 | Hochstufung | Kepler | Reduce → Hold |
| 2019-10-17 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | Herabstufung | Kepler | Hold → Reduce |
| 2019-10-08 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
Alle ansehen
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
Qiagen Reports Restricted Stock Unit Grant to Supervisory Board Member - The Globe and Mail
Qiagen discloses RSU vesting and share settlement for board member Eva Pisa - The Globe and Mail
Qiagen Reports Higher Stake by Massachusetts Financial Services in Voting Rights Disclosure - TipRanks
PTA-NVR: QIAGEN N.V.: Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView
Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Qiagen N.V. (NYSE:QGEN) Sees Significant Growth in Short Interest - MarketBeat
Qiagen Discloses Executive Equity Award Vesting Under Long-Term Incentive Plan - TipRanks
QIAGEN discloses equity award transaction by CFO Roland Sackers - TipRanks
QIAGEN Reports Supervisory Board Member’s Restricted Stock Unit Release - TipRanks
Qiagen Discloses Manager’s Restricted Stock Unit Vesting and Share Settlement - TipRanks
QIAGEN reports executive equity award vesting under MAR disclosure rules - TipRanks
Qiagen reports executive performance stock unit release and net share settlement - TipRanks
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView
Managers' transactions announcement according to article 19 MAR - TradingView
Qiagen N.V. (QGEN) Presents at Morgan Stanley European Healthcare ConferenceSlideshow - Seeking Alpha
Intech Investment Management LLC Invests $3.27 Million in Qiagen N.V. $QGEN - MarketBeat
Qiagen CEO says working with advisers on strategic review (QGEN:NYSE) - Seeking Alpha
Qiagen NV (QGEN) Trading Down 3.11% on Mar 2 - GuruFocus
QIAGEN engages advisors to review strategic alternatives - StreetInsider
getLinesFromResByArray error: size == 0 How Qiagen N.V. stock performs in rate cut cyclesJuly 2025 Outlook & Safe Entry Point Identification - mfd.ru
Qiagen N.V. (QGEN) Stock Report: Potential 10.91% Upside With Strong Buy Ratings - DirectorsTalk Interviews
JPMorgan Chase & Co. Sells 512,299 Shares of Qiagen N.V. $QGEN - MarketBeat
QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - Pressetext
Surge in Options Trading Volume for nLight and Qiagen - Intellectia AI
Goldman Sachs Discloses 3.11% Stake in Qiagen via AFM Filing - TipRanks
Release according to Article 40, Section 1 of the WpHG - TradingView
Is Qiagen N.V. in a long term uptrendRate Hike & Daily Market Momentum Tracking - mfd.ru
Vanguard Group Inc. Raises Holdings in Qiagen N.V. $QGEN - MarketBeat
Zacks Research Issues Negative Outlook for Qiagen Earnings - MarketBeat
Total non-current assets of QIAGEN NV – XETR:QIA - TradingView
QGEN Should I Buy - Intellectia AI
Traders Purchase Large Volume of Call Options on Qiagen (NYSE:QGEN) - MarketBeat
Qiagen NV at Citi Global Healthcare Conference Transcript - GuruFocus
Qiagen N.V. (QGEN) Stock Analysis: Exploring a 13.71% Upside Potential in the Diagnostics & Research Sector - DirectorsTalk Interviews
Big Money Moves: Can Qiagen NV ride the EV wave2025 Sector Review & Momentum Based Trading Ideas - baoquankhu1.vn
Contrasting Qiagen (NYSE:QGEN) & Dermata Therapeutics (NASDAQ:DRMA) - Defense World
Jefferies Maintains Qiagen NV(QGEN.US) With Buy Rating, Maintains Target Price $59 - 富途牛牛
MACD Signal: Can Qiagen NV sustain its profitabilityQuarterly Trade Review & Trade Opportunity Analysis Reports - baoquankhu1.vn
Qiagen (NYSE:QGEN) Rating Increased to Buy at Wall Street Zen - MarketBeat
Trend Recap: Should I average down on Qiagen NV stock2025 Retail Activity & Verified Swing Trading Watchlists - baoquankhu1.vn
MFS New Discovery Series's Qiagen NV(QGEN) Holding History - GuruFocus
QIAGEN NV : Barclays gives a Buy rating - marketscreener.com
Qiagen discloses executive share-based compensation transaction - The Globe and Mail
BlackRock Discloses 10.68% Capital Interest and 11.8% Voting Stake in Qiagen - The Globe and Mail
Qiagen N.V.: Why This Quiet Biotech Stock Just Got Loud for US Investors - AD HOC NEWS
Traders Purchase High Volume of Put Options on Qiagen (NYSE:QGEN) - MarketBeat
New Evercode v4 lets labs profile 5M cells, recover 75% more - Stock Titan
Stifel Maintains Qiagen NV(QGEN.US) With Hold Rating, Raises Target Price to $50 - 富途牛牛
Statutory Profit Doesn't Reflect How Good Qiagen's (NYSE:QGEN) Earnings Are - Yahoo Finance
Qiagen NV (QGEN) Shares Down 3.25% on Feb 17 - GuruFocus
Finanzdaten der Qiagen Nv-Aktie (QGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.04%
0.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):